Oral health condition in cancer patients under bisphosphonate therapy

被引:5
|
作者
Caldas, Rogerio Jardim [1 ,2 ]
Antunes, Heliton Spindola [3 ]
Rodini Pegoraro, Camila de Oliveira [4 ]
Guedes, Fabio Ribeiro [5 ]
da Silva Santos, Paulo Sergio [2 ]
机构
[1] Mario Kroeff Hosp, Dept Dent, Rio De Janeiro, Brazil
[2] Univ Sao Paulo, Bauru Sch Med, Dept Surg Stomatol Pathol & Radiol, Alameda Dr Octavio Pinheiro Brisolla 9-75, BR-17012901 Bauru, SP, Brazil
[3] Natl Inst Canc, Div Clin Res & Technol Dev, Rio De Janeiro, Brazil
[4] Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil
[5] Univ Fed Rio de Janeiro, Fac Dent, Dept Pathol & Oral Diag, Rio De Janeiro, Brazil
关键词
Caries; Periodontal disease(s); periodontitis; Oral hygiene; Osteonecrosis; Oncology; Epidemiology; MEDICATION-RELATED OSTEONECROSIS; RISK-FACTORS; MULTIPLE-MYELOMA; ZOLEDRONIC ACID; PROSTATE-CANCER; JAW; ASSOCIATION; DENOSUMAB; BREAST;
D O I
10.1007/s00520-021-06362-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives To investigate the association of oral health condition with the occurrence of medication-related osteonecrosis of the jaw (MRONJ) in a cancer population. Methods A multicenter cross-sectional study was conducted with cancer patients exposed to bisphosphonates for at least 7 months. Dental and periodontal conditions were assessed by epidemiological indices. Results The sample consisted of 80 patients under bisphosphonate therapy, nine of which were allocated to group 1 (with MRONJ) and 71 to group 2 (without MRONJ). Osteonecrosis cases presented 19 decayed, missing, and filled teeth on average. Moderate gingival inflammation was noted in both groups and together with severe inflammation exceeded 50% of the groups. The presence of dental calculus was detected in about half of the individuals in both groups. Shallow periodontal pockets were detected in about 25% of both groups. Deep periodontal pockets were more prevalent among patients with osteonecrosis. Regular oral hygiene was detected in approximately 25% of individuals in both groups. There was a strong positive correlation between the clinical staging of osteonecrosis and decayed, missing, and filled teeth index (DMFTI). Conclusions Patients had a poor oral health condition. All but one osteonecrosis case had no previous history of tooth extraction; oral infections seemed to play a major role in the development of bone necrosis. Advanced osteonecrosis stages were associated with a higher DMFTI.
引用
收藏
页码:7687 / 7694
页数:8
相关论文
共 50 条
  • [21] ORAL HEALTH CONDITION IN SCHOOLCHILDREN UNDER PREVENTIVE PROGRAM
    CANTON, L
    DONO, R
    CASTRO, M
    FERNANDEZ, MY
    PISTOCHINI, A
    JOURNAL OF DENTAL RESEARCH, 1986, 65 (04) : 469 - 469
  • [22] Under-prescribing of prophylactic oral bisphosphonate therapy for osteoporotic type fractures
    Bennett, K.
    McGowan, B.
    Feely, J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (07) : 742 - 743
  • [23] Under-prescribing of prophylactic oral bisphosphonate therapy for osteoporotic type fractures
    Bennett, Kathleen
    McGowan, Bernadette
    Feely, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S73 - S73
  • [24] IMPROVED ADHERENCE TO ORAL BISPHOSPHONATE THERAPY
    Moore, A. E. B.
    Perera, D.
    Singh, P.
    Clarke, R. E. J.
    Hampson, G.
    Fogelman, I.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S689 - S690
  • [25] Bisphosphonate medications and your oral health
    不详
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2006, 137 (07): : 1048 - 1048
  • [26] Subtrochanteric stress fractures in patients on oral bisphosphonate therapy: an emerging problem
    Murphy, Colin G.
    O'Flanagan, Shay
    Keogh, Peter
    Kenny, Patrick
    ACTA ORTHOPAEDICA BELGICA, 2011, 77 (05): : 632 - 637
  • [27] Intravenous Bisphosphonate Therapy and Risk of Atrial Fibrillation in Cancer Patients
    Erichsen, Rune
    Christiansen, Christian F.
    Froslev, Trine
    Jacobsen, Jacob
    Sorensen, Henrik T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S121 - S121
  • [28] Prolonged bone health benefits for breast cancer patients following adjuvant bisphosphonate therapy: the BoHFAB study
    Brown, Janet
    Paggiosi, Margaret A.
    Rathbone, Emma
    Gregory, Walter
    Bertelli, Gian
    Din, Omar
    McCloskey, Eugene
    Dodwell, David
    Cameron, David
    Eastell, Richard
    Coleman, Robert
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 (01) : 8 - 16
  • [29] Oral bisphosphonate use and colorectal cancer incidence in the Women's Health Initiative
    Passarelli, Michael N.
    Newcomb, Polly A.
    LaCroix, Andrea Z.
    Lane, Dorothy S.
    Ho, Gloria Y. F.
    Chlebowski, Rowan T.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (09) : 2043 - 2048
  • [30] Persistence among osteoporotic patients having started weekly oral bisphosphonate therapy
    Sheehy, Odile
    Kindundu, Christian
    Barbeau, Martin
    LeLorier, Jacques
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S12 - S12